Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty

BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...

Full description

Saved in:
Bibliographic Details
Published in:Patient Saf Surg
Main Authors: Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S.
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://ncbi.nlm.nih.gov/pubmed/33975621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13037-021-00295-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items